Tradestie Institutional Equity Comparison Engine

ENSC vs OLB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while OLB counters with relative strength in Growth & Margin. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus OLB at N/M Forward P/E and -73.3% operating margin (-43.6% YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OLB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
ENSC 0.8x vs OLB N/M Fwd P/E
Growth & Margin Winner OLB
Op Margin -281.3% vs -73.3% ยท YoY -15.1% vs -43.6%
Momentum & Technical Winner ENSC
1Y -80.3% vs -87.4% ยท 52W Pos 8% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0
OLB NASDAQ
The OLB Group, Inc. Common Stock
Services-Business Services, Nec
$0.12
-4.33% 1D
Market Cap $3.8M
1M Return -63.26%
1Y Return -87.36%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 48.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENSC -80.33% OLB -87.36% Spread: +7.03 pp (ENSC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENSC Revenue OLB Revenue ENSC Op. Margin OLB Op. Margin Margin Edge
FY2018 N/A $10M N/A 5.9% OLB
FY2019 N/A $10M N/A -2.6% OLB
FY2020 $0M $10M -41.0% -7.5% OLB
FY2021 $0M $20M -562.7% -28.5% OLB
FY2022 $0M $30M -959.9% -26.9% OLB
FY2023 $0M $30M -480.5% -76.8% OLB
FY2024 $10M $10M -129.2% -90.9% OLB
FY2025 $10M $10M -202.1% -59.5% OLB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENSC (6) vs OLB (3)
Institutional Metric ENSC OLB Criterion Row Winner
Market Capitalization Scale $7.0M $3.8M Larger Scale Tie
Trailing P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Forward P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Revenue Growth (YoY) Growth -15.1% -43.6% Higher Growth ENSC
Operating Margin (TTM) Profitability -281.3% -73.3% Higher Margin OLB
Net Profit Margin Profitability -280.5% -68.2% Higher Margin OLB
Return on Equity (ROE) Capital Efficiency -1295.1% -70.8% Higher ROE OLB
52-Week Range Position Momentum 8% ($0โ€“$2) 0% ($0โ€“$2) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 0.98ฮฒ ยท 79% Vol 1.80ฮฒ ยท 120% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 53.4 / 100 (HOLD) 48.6 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENSC vs OLB Buy Guide
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OLB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OLB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENSC nor OLB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.